News

Valsource names Jeffrey L. Hartman Senior Validation and QRM Consultant

ValSource announced Jeffrey L. Hartman has joined North America’s largest independent validation services company as a Senior Validation and Quality Risk Management (“QRM”) Consultant. Prior to ValSource, Jeff Hartman spent 34 years with Merck, most recently serving as Director of Validation Quality Systems for Merck Manufacturing Division.

Considering his future with ValSource, Hartman commented, “Candidly, I’m past the point of having to work. I’m relishing working with such a great company. ValSource’s vision of returning validation to a vital, valuable tool for companies aligns perfectly with my own professional philosophy.” He continued, “I’m energized and look forward to the knowledge transfer process with ValSource’s clients….

View Post

Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride.

Kim, Ahn, LiPuma, Hussong, and Cerniglia. 2015. Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride. Journal of Industrial Microbiology & Biotechnology. Date: 21 Mar 2015 (online) http://link.springer.com/article/10.1007/s10295-015-1605-x

Abstract

The Burkholderia cepacia complex (BCC) includes opportunistic pathogenic bacteria that have occasionally been recovered from various pharmaceutical products, including antiseptics and disinfectants. Plausible reasons for the contamination include intrinsic sources, such as inadequate process controls, especially for water or equipment used during product manufacture, or extrinsic sources, such as improper handling and dilution or distribution in contaminated containers….

View Post

ValSource Names Dr. David Hussong Senior Microbiology and Regulatory Consultant

ValSource announced David Hussong, Ph.D. has joined the company as Senior Microbiology and Regulatory Consultant. David Hussong has spent most of his entire career, more than 30 years, at the Food and Drug Administration. For the last decade he served as Supervisor of the New Drug Microbiology Staff in the Office of Pharmaceutical Science (“OPS”) and as the Associate Director for New Drug Microbiology, OPS – Center for Drug Evaluation and Research (“CDER”). There, his work encompassed significant policy and scientific influence in all matters of review of microbiology issues and products applications….

View Post

ValSource Undergoes Corporate Rebrand

ValSource, LLC, today announced, after an extensive strategic branding exercise, the company recently underwent the first significant rebrand in its nearly 20-year history. The rebrand centers on the tagline and brand theme: Validation. Delivered. The rebrand was motivated by ValSource’s desire to distinguish its elite validation services and better reflect its singular focus on returning validation to a scientific event which helps companies design, perform and control better manufacturing processes throughout all stages of the operations life cycle.

The new brand essence and elements communicate ValSource’s elite validation solution, which addresses the continuum of all the related processes, delivers a sustainably reliable product and has a measurable value to better performance….

View Post